In pairwise comparisons, the plasma HSP90α showed significantly higher levels in HCC patients when compared to the HH and SHC patients groups (p < 0.001 and p = 0.011, respectively). This evidence concerns the gene HSP90AA1 and hepatocellular carcinoma.